Asaretoclax
Asaretoclax is a potent B-cell lymphoma 2 (Bcl-2) inhibitor. Asaretoclax has the potential for the research of cancer[1].
Product Specifications
CAS Number
2363074-01-3
UNSPSC
12352005
Target
Bcl-2 Family
Type
Reference compound
Related Pathways
Apoptosis
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/asaretoclax.html
Smiles
FC(F)C(C1)(C2)CC12C(CC(C)(CC3)C)=C3CN4CCN(C5=CC(OC6=CN=C(NC=C7)C7=C6)=C(C=C5)C(NS(=O)(C8=CC([N+]([O-])=O)=C(C=C8)NC[C@H]9CC[C@](O)(CC9)C)=O)=O)CC4
Molecular Formula
C47H57F2N7O7S
Molecular Weight
902.06
References & Citations
[1]WHO Drug Information. Volume 38, No. 2.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PKSH033807-01 10 µg
Recombinant Human/Mouse/Rat Activin A/INHBA Protein
Sign In for Pricing
View Details PKSH033807-02 50 µg
Recombinant Human/Mouse/Rat Activin A/INHBA Protein
Sign In for Pricing
View Details 
BNC402406-500 1x 500 µL
Bcl-X (Apoptosis Marker) (BCL2L1/2406), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 